Atlas Trials

Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia

Clinical trial NCT07102069 · COMPLETED

Trial details

NCT number
NCT07102069
Sponsor
Tianjin Anding Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2017-11-01
Primary completion
2022-06-14
Enrollment
384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.